Osborn to Remain as Advisor to Company
FRAZER, Pa., Feb. 8 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) today announced that its Executive Vice President, General Counsel & Secretary, John E. Osborn, has decided to resign his position with the company, effective March 31. Mr. Osborn has agreed to remain as an advisor to the company on significant legal and policy matters.
"John has been an invaluable member of our senior executive team and is an exceptionally talented lawyer. On behalf of the board of directors and executive team, I want to express my appreciation for his more than 10 years of outstanding contributions and assistance in building Cephalon into one of the leading biopharmaceutical companies in the world," said Frank Baldino, Jr., Ph.D., Chairman and CEO. "I also am pleased that John has agreed to continue to advise the company and to assist in ensuring an effective transition," Dr. Baldino added.
Mr. Osborn has accepted an appointment as a visiting fellow with the Centre for Socio-Legal Studies at the University of Oxford for the spring 2008 term, and will be associated with Wadham College Oxford. He also will serve as an advisor on life sciences regulatory and compliance matters to the international consulting firm McKinsey & Company, Inc. In 2007, Mr. Osborn was nominated by President George W. Bush to the United States Advisory Commission on Public Diplomacy, which is pending confirmation by the U.S. Senate. He has also served as a member of the Board of Governors of the East- West Center in Honolulu, a research and education and organization focused on the Asia Pacific region, and was an Eisenhower Fellow to Northern Ireland in 1998.
Mr. Osborn joined Cephalon in March 1997 and was promoted to General
Counsel in 1998. During his tenure, he has managed the legal, government,
corporate and public affairs functions, in addition to quality assurance
and compliance. Among his many accomplish
|SOURCE Cephalon, Inc.|
Copyright©2008 PR Newswire.
All rights reserved